Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-23-000274

Options or other derivatives

  • Chief Executive Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. Chief Executive Officer 2023-01-03 Grant or award · Stock Option (Right to Buy) +300,000 $0.41 $123,000 2,542,395 D
Loading xslF345X03/ownership.xml…